Quoted from http://www.bloomberg.com/apps/news?pid=newsarchive&sid=aMBoIgCxlUx0
Pfizer Unit Must Pay Prempro Damages, Jury Concludes
By Jef Feeley and Sophia Pearson
Oct. 23 (Bloomberg) -- A Pfizer Inc. unit concealed the breast-cancer risks of its hormone-replacement therapy drug Prempro and is liable for $3.7 million in damages to an Illinois woman, a Philadelphia jury ruled in the second phase of a trial.
Connie Barton, 64, developed invasive breast cancer five years after she began taking Prempro, made by Pfizer’s Wyeth unit. The same jury ruled Sept. 25 that the menopause drug caused her cancer and awarded her $3.7 million in compensatory damages. After deliberating for 45 minutes, jurors ruled today that Wyeth was at fault and is liable for the compensatory damages.
“The jury will return” next week to consider a punitive damage award against Wyeth, Philadelphia Common Pleas Judge Norman Ackerman said after the verdict today. Jurors will begin deliberating on the issue Oct. 26.
More than 6 million women have taken hormone-replacement medicines to treat menopause symptoms such as hot flashes, night sweats and mood swings. Until 1995, many patients combined Premarin, Wyeth’s estrogen-based drug, with progestin-laden Provera, made by Upjohn, another Pfizer unit.